Hospital
Citrus Memorial Hospital, INC.
Citrus Memorial Hospital, INC. was paid $7.71M by Medicaid between Jan 2018 and Dec 2024, across 125 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoCITRUS MEMORIAL HOSPITAL, INC.
INVERNESS, FL 34452
INVERNESS, FL 34452
33aNPI1750780342assigned 08/19/2014
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.71M
24GClaims275,498
24DCodes billed125
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#64 of 163
Median peer was paid$4.77M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,965 | $310K | |
| 2019 | 53,749 | $1.37M | |
| 2020 | 46,678 | $1.12M | |
| 2021 | 54,844 | $1.53M | |
| 2022 | 49,817 | $1.70M | |
| 2023 | 31,550 | $1.07M | |
| 2024incomplete | 14,895 | $617K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 27,506 | 24,392 | $2.20M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 19,193 | 16,535 | $1.05M |
| 96361 | Intravenous infusion, hydration; each additional hour | 8.1% | 2,987 | 2,631 | $626K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.4% | 2,739 | 2,465 | $491K |
| 36415 | Collection of venous blood by venipuncture | 6.3% | 23,715 | 18,530 | $482K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.7% | 7,123 | 1,527 | $440K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.6% | 3,794 | 3,103 | $435K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 2,930 | 2,660 | $207K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.6% | 1,514 | 1,335 | $199K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.1% | 3,020 | 2,550 | $165K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.1% | 917 | 809 | $160K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.7% | 1,396 | 1,288 | $133K |
113 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 624 | $111K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 3,690 | $80K |
| 80053 | Comprehensive metabolic panel | <1% | 16,465 | $67K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 764 | $66K |
| 87070 | <1% | 2,230 | $53K | |
| 59025 | Fetal non-stress test | <1% | 876 | $49K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,432 | $48K |
| 87400 | <1% | 3,968 | $33K | |
| G0378 | Hospital observation service, per hour | <1% | 2,141 | $32K |
| 81001 | <1% | 10,032 | $32K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 560 | $31K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 307 | $30K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,022 | $30K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,113 | $29K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,927 | $27K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,905 | $26K |
| 87040 | <1% | 1,243 | $19K | |
| 85027 | <1% | 22,580 | $18K | |
| 86850 | <1% | 1,470 | $18K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 555 | $17K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,779 | $16K |
| 97597 | <1% | 353 | $14K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,857 | $13K |
| 97162 | <1% | 369 | $12K | |
| 87088 | <1% | 2,601 | $12K | |
| A9270 | Non-covered item or service | <1% | 3,609 | $12K |
| 73610 | <1% | 393 | $12K | |
| 87430 | <1% | 2,750 | $11K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 910 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 10,028 | $11K |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 65 | $10K |
| 74018 | <1% | 694 | $10K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 67 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,073 | $10K |
| 76801 | <1% | 437 | $9K | |
| 97161 | <1% | 258 | $9K | |
| 85610 | <1% | 5,183 | $8K | |
| 73630 | <1% | 464 | $8K | |
| 84484 | <1% | 5,851 | $7K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 205 | $7K |
| 73562 | <1% | 432 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,986 | $6K |
| 81025 | <1% | 3,058 | $6K | |
| 80076 | <1% | 1,933 | $6K | |
| 73030 | <1% | 363 | $5K | |
| 93971 | <1% | 237 | $5K | |
| 87420 | <1% | 724 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 199 | $4K |
| 85730 | <1% | 2,504 | $3K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,341 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,787 | $3K |
| 83690 | <1% | 3,861 | $3K | |
| 83880 | <1% | 1,703 | $3K | |
| 86900 | <1% | 1,840 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 941 | $3K |
| 73130 | <1% | 216 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 243 | $2K |
| 72100 | <1% | 174 | $2K | |
| 83735 | <1% | 2,820 | $2K | |
| 73110 | <1% | 72 | $2K | |
| 81003 | <1% | 1,568 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 270 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 107 | $1K |
| 12001 | <1% | 29 | $1K | |
| 82150 | <1% | 1,148 | $989.87 | |
| 72131 | <1% | 17 | $982.93 | |
| 82248 | <1% | 904 | $948.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 18 | $915.09 |
| 76830 | Ultrasound, transvaginal | <1% | 28 | $902.16 |
| 84702 | <1% | 3,154 | $780.86 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 328 | $757.99 |
| 87186 | <1% | 521 | $755.29 | |
| 86901 | <1% | 1,791 | $698.27 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,070 | $685.41 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 62 | $681.50 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 147 | $617.54 |
| 93017 | <1% | 13 | $570.43 | |
| C1769 | Guide wire | <1% | 93 | $546.13 |
| 83605 | <1% | 709 | $529.64 | |
| J2704 | Injection, propofol, 10 mg | <1% | 130 | $526.12 |
| 70486 | <1% | 16 | $448.75 | |
| 82805 | <1% | 33 | $437.75 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 680 | $412.54 |
| 76770 | <1% | 14 | $400.71 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 88 | $367.70 |
| 80061 | Lipid panel | <1% | 272 | $362.98 |
| 90714 | <1% | 138 | $321.35 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 137 | $303.24 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 35 | $301.03 |
| J3490 | Unclassified drugs | <1% | 130 | $282.12 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 127 | $254.54 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 256 | $222.06 |
| 73502 | <1% | 31 | $147.51 | |
| 87205 | <1% | 93 | $87.90 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 39 | $71.81 |
| 85379 | <1% | 26 | $60.90 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 42 | $46.62 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 50 | $45.88 |
| 96376 | <1% | 587 | $23.07 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 123 | $0.00 |
| 84703 | 0% | 13 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 45 | $0.00 |
| 82077 | 0% | 14 | $0.00 | |
| 86140 | 0% | 27 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 12 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 68 | $0.00 |
| 99152 | 0% | 16 | $0.00 | |
| 36600 | 0% | 14 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 17 | $0.00 |
| 80143 | 0% | 69 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 14 | $0.00 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 35 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIGGINS, ZACHARY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Centerpoint Medical Center of Independence, LLC | Independence, MO | $38.66M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.